Cysteine-Linked ADC Purification via HIC Salt Gradient
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying cysteine-linked antibody-drug conjugates (ADCs) face challenges in scaling up the purification process, particularly for mixtures with high amounts of non-conjugated antibody, often requiring multiple chromatographic steps and the use of organic solvents, which are not acceptable for industrial-scale processes.
Innovation Solution
A method involving preparative hydrophobic interaction chromatography (HIC) is used, where a mixture of cysteine-linked ADCs in a 0.2-1.5 M aqueous salt solution is loaded onto a HIC column, with a flow-through fraction containing non-conjugated antibody collected, and the column washed and eluted with a 0-100 mM aqueous salt solution to obtain a purified mixture of cysteine-linked ADCs, avoiding the use of organic solvents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multiple chromatographic steps are used for purification, then purity of Cys-linked ADCs is improved, but device complexity and process time increase
Solution Approach 1:
The purification process is segmented into two functional stages within a single HIC column: (1) a flow-through stage that removes non-conjugated antibody and hydrophilic impurities, and (2) an elution stage that recovers purified Cys-linked ADCs. This segmentation allows complex purification to be achieved through a single column operation rather than multiple sequential chromatographic steps.
Solution Approach 2:
The method utilizes changes in salt concentration parameters to control the hydrophobic interaction between the ADCs and the HIC column matrix. By adjusting the salt gradient from high to low concentration, the method selectively elutes different DAR species, achieving high purity separation without requiring multiple columns or complex instrumentation.
2Manufacturing precision
If organic solvents are used in chromatography, then separation efficiency is improved, but safety and environmental compatibility worsen
Solution Approach 1:
The method replaces organic solvent-based chromatography with aqueous salt solution-based HIC. By changing the solvent system from organic to aqueous and adjusting salt concentration parameters, the method achieves comparable or superior separation efficiency while eliminating the safety and environmental hazards associated with organic solvents.
Solution Approach 2:
The method converts the typically harmful organic solvent step into a beneficial aqueous-based process. The hydrophobic interaction mechanism, which could have required organic solvents, is instead exploited using aqueous salt solutions, turning a potential hazard into a safe and environmentally friendly purification approach.
3Productivity
If flow rate is increased for faster processing, then productivity is improved, but separation precision deteriorates
Solution Approach 1:
The method performs preliminary separation of non-conjugated antibody in the flow-through fraction before the main elution step. This preliminary action occurs at high flow rate without compromising final precision because the hydrophobic ADCs are already selectively retained on the column while hydrophilic impurities are rapidly removed, allowing high productivity to be maintained throughout the process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively purifies cysteine-linked ADCs with an average drug-to-antibody ratio of 2-3, reducing the amount of non-conjugated antibody from 10-40% by weight, suitable for industrial-scale production without the need for multiple chromatographic steps or organic solvents.
Implementation Method 1
preparative hydrophobic interaction chromatography (HIC) is used, where a mixture of cysteine-linked ADCs in a 0.2-1.5 M aqueous salt solution is loaded onto a HIC column
Implementation Method 2
the column washed and eluted with a 0-100 mM aqueous salt solution to obtain a purified mixture of cysteine-linked ADCs
Data Source
AI summary
The present invention relates to a method for purifying a mixture of cysteine-linked antibody-drug conjugates, wherein the amount of non-conjugated antibody is in the range of 0-40% by weight, using hydrophobic interaction chromatography (HIC). The mixture is loaded onto a preparative HIC column using a 0.2-1.5 M aqueous salt solution, in which non-conjugated antibody is collected in a flow-through fraction, followed by elution of a purified mixture of cysteine-linked antibody-drug conjugates using a 0-100 mM aqueous salt solution.